How New Machine Learning Models Can Help Diagnose Women’s Heart Disease
Researchers in the U.S. and the Netherlands have now used a large dataset to build more accurate cardiovascular risk models.
Researchers in the U.S. and the Netherlands have now used a large dataset to build more accurate cardiovascular risk models.
Clinicians can now use two new biomarker-based assays in combination to determine which patients are at higher risk for poor outcomes.
Scopio Labs received De Novo clearance from the FDA for its Full-Field Bone Marrow Aspirate (FF-BMA) Application.
Verichem Laboratories upgraded its web-based, CLIA-compliant data reduction and test reporting software program.
The lab-developed test will help diagnose Long COVID and is aimed to provide accurate insights into personalized treatment approaches.